Identification of lysine residues in the binding domain of ribonuclease A for the RNase inhibitor from human placenta.
Amidination of the available lysine residues of the complex between RNase A and human placental RNase inhibitor has been performed with methyl acetimidate; the conditions of the derivatization preserve the complex functionally intact. Resistance of epsilon-acetimidyllysine residues to hydrolysis by trypsin allowed, after peptide mapping, the identification of lysine residues 7, 31, 41, 61, and 91 as those which were fully protected by the inhibitor from amidination. Lysine residue 37 was partially protected from amidination. In the presence of poly(A), lysine residues 41 and 61 of RNase A were fully protected from amidination, while lysine residues 7, 31, 37, 91, and 104 were only partially protected; the enzyme retained full activity. The results permit identification of lysine residues located in the binding domain of RNase A for the inhibitor. This region is not identical with, but does overlap, the binding domain for poly(A).
D000596:Amino Acids / Q000032:analysis; D002851:Chromatography, High Pressure Liquid; D004720:Endonucleases / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D007700:Kinetics; D008239:Lysine; D010446:Peptide Fragments / Q000032:analysis; D010920:Placenta / Q000502:physiology*; D010926:Placental Hormones / Q000494:pharmacology*; D011247:Pregnancy; D011485:Protein Binding; D012259:Ribonuclease, Pancreatic; D012260:Ribonucleases / Q000037:antagonists & inhibitors*
D000596:Amino Acids; D010446:Peptide Fragments; D010926:Placental Hormones; C022052:placental ribonuclease inhibitor; D004720:Endonucleases; D012260:Ribonucleases; D012259:Ribonuclease, Pancreatic; D008239:Lysine